“…These methods are fast, user-friendly, and reliable and promise to be invaluable in the development of proteins with a wide range of impactful applications. The applications of these tools extend from understanding the origin of diseases caused by misregulation of protein maintenance [ 51 , 52 ] to discriminating disease-associated mutations from non-disease mutations, studying drug-resistant mutations [ 53 , 54 , 55 ], and providing important structural and functional insights into designing new proteins [ 56 , 57 , 58 , 59 ]. To design DARPins as ERK2 inhibitors, a multi-point mutation approach, MAESTRO, was applied to the wild-type DARPin protein to identify the stabilizing mutation points, followed by validation of the binding energy of mutants employing MD simulations using MM-PBSA/GBSA protocols.…”